Log In
Print
BCIQ
Print
Print this Print this
 

PD01A

Also known as: PD01

  Manage Alerts
Collapse Summary General Information
Company Affiris AG
DescriptionVaccine that targets the alpha synuclein (SNCA) protein
Molecular Target Alpha synuclein (SNCA)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today